Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Do you treat bulky pelvic/retroperitoneal lymph nodes for prostate cancer to palliate lower extremity lymphedema?
If so, what dose do you use?
Answer from: Radiation Oncologist at Community Practice
Yes usually would use 35-40 Gy at 2.5 Gy per fraction
Sign In
or
Register
to read more
4815
Related Questions
How do you interpret nodes with minimal increased uptake on PSMA PET in prostate cancer?
How would you approach radiation for node-positive prostate cancer in a patient with an aortic and/or common iliac arterial aneurysm not meeting criteria for surgical repair?
In platinum-refractory or multiply-relapsed NSGCT with 1–2 progressive sites and no good surgical option, is there a role for local radiotherapy (e.g., SBRT) to those sites?
Do you recommend neoadjuvant 177Lu-PNT2002 followed by MDT per the LUNAR trial as your preferred treatment approach for oligorecurrent prostate cancer, as opposed to MDT and PSMA-radioligand therapy used as temporally separate treatments?
What are your top takeaways in GU Cancers from ESMO 2025?
How would you treat a patient with isolated CNS relapse of seminoma?
How would you manage a medically inoperable patient with locally recurrent nest variant muscle invasive urothelial carcinoma s/p radical cystectomy years ago now involving the urethral anastomosis, sphincter and neo-bladder, status post TUR?
How do you approach ADT in patients with high-risk prostate cancer who have risk factors for VTE, such as Factor V Leiden?
For patients starting Pluvicto, do you have patients stop their ARPI?
How do you interpret recent large retrospective analyses comparing radical prostatectomy vs. radiation for prostate cancer?